Journal of Current Glaucoma Practice

Register      Login

VOLUME 13 , ISSUE 2 ( May-August, 2019 ) > List of Articles

EDITORIAL

Revisiting Results of Conventional Surgery: Trabeculectomy, Glaucoma Drainage Devices, and Deep Sclerectomy in the Era of MIGS

Shibal Bhartiya, Deepika Dhingra, Tarek Shaarawy

Citation Information : Bhartiya S, Dhingra D, Shaarawy T. Revisiting Results of Conventional Surgery: Trabeculectomy, Glaucoma Drainage Devices, and Deep Sclerectomy in the Era of MIGS. J Curr Glaucoma Pract 2019; 13 (2):45-49.

DOI: 10.5005/jp-journals-10078-1248

License: CC BY-NC 4.0

Published Online: 00-08-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Gabal A, Cimarosti R, et al. Efficacy and safety of trabeculectomy vs non-penetrating surgeries in open-angle glaucoma: a meta-analysis. J Glaucoma 2019 Jul 18. DOI: 10.1097/IJG. 0000000000001323.
  2. Sawchyn AK, Slabaugh MA. Innovations and adaptations in trabeculectomy. Curr Opin Ophthalmol 2016;27:158–163. DOI: 10.1097/ICU.0000000000000236.
  3. Tseng VL, Coleman AL, et al. Aqueous shunts for glaucoma. Cochrane Database Syst Rev 2017 Jul 28;7:CD004918. DOI: 10.1002/14651858.CD004918.pub3.
  4. Lavia C, Dallorto L, et al. Minimally minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One 2017;12:e0183142. DOI: 10.1371/journal.pone.0183142.
  5. Vinod K, Gedde SJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society. J Glaucoma 2017;26:687–693. DOI: 10.1097/IJG.0000000000000720.
  6. Bloom P, Au L. Minimally invasive glaucoma surgery (MIGS) is a poor substitute for trabeculectomy—the great debate. Ophthalmol Ther 2018;7:203–210. DOI: 10.1007/s40123-018-0135-9.
  7. Aslan F, Yuce B, et al. Evaluation of the learning curve of non-penetrating glaucoma surgery. Int Ophthalmol 2018;38:2005–2012. DOI: 10.1007/s10792-017-0691-3.
  8. Al-Mugheiry TS, Cate H, et al. Microinvasive Glaucoma Stent (MIGS) Surgery with Concomitant Phakoemulsification Cataract Extraction: Outcomes and the Learning Curve. J Glaucoma 2017;26:646–651. DOI: 10.1097/IJG.0000000000000691.
  9. Craven ER, Katz LJ, et al. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg 2012;38:1339–1345. DOI: 10.1016/j.jcrs.2012.03.025.
  10. Arriola-Villalobos P, Martínez-de-la-Casa JM, et al. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol 2012;96:645–649. DOI: 10.1136/bjophthalmol-2011-300218.
  11. Fea AM, Consolandi G, et al. Micro-Bypass Implantation for Primary Open Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up. J Ophthalmol 2015;2015:795357. DOI: 10.1155/2015/795357.
  12. Arriola-Villalobos P, Martinez-de-la-Casa JM, et al. Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study. J Ophthalmol 2016;2016:1056573. DOI: 10.1155/2016/1056573.
  13. Katz JL, Erb C, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol 2015;9:2313–2320. DOI: 10.2147/OPTH.S96695.
  14. Pfeiffer N, Garcia-Feijoo J, et al. A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma. Ophthalmology 2015;122: 1283–1293. DOI: 10.1016/j.ophtha.2015.03.031.
  15. Gandolfi SA, Ungaro N, et al. Comparison of surgical outcomes between canaloplasty and Schlemm's canal scaffold at 24 months’ follow-up. J Ophthalmol 2016;5:3410469. DOI: 10.1155/2016/3410469.
  16. Widder RA, Dietlein TS, et al. The Xen45 gel stent as a minimally invasive procedure in glaucoma surgery: Success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol 2018;256:765–771. DOI: 10.1007/s00417-018-3899-7.
  17. Batlle JF, Fantes F, et al. Three-Year Follow-up of a Novel Aqueous Humor Micro Shunt. J Glaucoma 2016;25:e58–e65. DOI: 10.1097/IJG.0000000000000368.
  18. Francis BA, Berke SJ, et al. Endoscopic cyclophotocoagulation combined with phacoemulsification vs phacoemulsification alone in medically controlled glaucoma. J Cataract Refract Surg 2014;40: 1313–1321. DOI: 10.1016/j.jcrs.2014.06.021.
  19. Siegel MJ, Boling WS, et al. Combined endoscopic cyclophotocoagulation and phacoemulsification vs phacoemulsification alone in the treatment of mild to moderate glaucoma. Clin Exp Ophthalmol 2015;43:531–539. DOI: 10.1111/ceo.12510.
  20. Haibo T, Xin K, et al. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis. PLoS One 2015;10:e0118142. DOI: 10.1371/journal.pone.0118142.
  21. Namavari A, Hyde RA, et al. Primary Baerveldt shunt implantation: Outcomes and complications. Ophthalmol Ther 2016;5:253–262. DOI: 10.1007/s40123-016-0056-4.
  22. Cheng JW, Xi GL, et al. Efficacy and tolerability of nonpenetrating glaucoma surgery augmented with mitomycin C in treatment of open-angle glaucoma: a meta-analysis. Can J Ophthalmol 2009;44:76–82. DOI: 10.3129/i08-165.
  23. De Gregorio A, Pedrotti E, et al. Minimally invasive combined glaucoma and cataract surgery: clinic results of the smallest ab interno gel stent. Int Ophthalmol 2018;38:1129–1134. DOI: 10.1007/s10792-017-0571-x.
  24. Patel I, de Klerk TA, et al. Manchester iStent study: early results from a prospective UK case series. Clin Exp Ophthalmol 2013;41:648–652. DOI: 10.1111/ceo.12098.
  25. Belovay GW, Nagi A, et al. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg 2012;38:1911–1917. DOI: 10.1016/j.jcrs.2012.07.017.
  26. Gandolfi SA, Ungaro N, et al. Comparison of surgical outcomes between canaloplasty and Schlemm's canal scaffold at 24 months’ follow-up. J Ophthalmol 2016;5:3410469. DOI: 10.1155/2016/3410469.
  27. Vold S, Ahmed IK, et al. Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open angle glaucoma and cataracts. Ophthalmology 2016;123:2103–2112. DOI: 10.1016/j.ophtha.2016.06.032.
  28. Gedde SJ, Schiffman JC, et al. Treatment outcomes in the tube vs trabeculectomy (TVT) Study after five years of follow-up. Am J Ophthalmol 2012;153:789–803. DOI: 10.1016/j.ajo.2011.10.026.
  29. Budenz DL, Barton K, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 2015;122: 308–316. DOI: 10.1016/j.ophtha.2014.08.043.
  30. Hoeh H, Vold SD, et al. Initial clinical experience with the CyPass micro-stent: Safety and surgical outcomes of a novel supraciliary microstent. J Glaucoma 2016;25:106–112. DOI: 10.1097/IJG.0000000000000134.
  31. Galal A, Bilgic A, et al. Xen glaucoma implant with mitomycin-C 1-year follow-up: result and complications. J Ophthalmol 2017;2017:5457246. DOI: 10.1155/2017/5457246.
  32. Tran DH, Souza C, et al. Comparison of long-term surgical success of Ahmed valve implant vs trabeculectomy in open-angle glaucoma. Br J Ophthalmol 2009;93:1504–1509. DOI: 10.1136/bjo.2008.150870.
  33. Brandão LM, Grieshaber MC. Update on Minimally Invasive Glaucoma Surgery (MIGS) and New Implants. J Ophthalmol 2013;2013:705915. DOI: 10.1155/2013/705915.
  34. Zhou M, Wang W, et al. Trabeculectomy with vs without releasable sutures for glaucoma-A meta-analysis of randomized controlled trials. BMC Ophthalmol 2014;14:41. DOI: 10.1186/1471-2415-14-41.
  35. Casson R, Rahman R, et al. Long term results and complications of trabeculectomy with low dose mitomycin C in patients at risk of filtration failure. Br J Ophthalmol 2001;85:686–688. DOI: 10.1136/bjo.85.6.686.
  36. Garcia-Feijoo J, Rau M, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol 2015;159:1075–1081. DOI: 10.1016/j.ajo.2015.02.018.
  37. Popovic M, Campos-Moller X, et al. Efficacy and Adverse Event Profile of the iStent and iStent Inject Trabecular Micro-bypass for Open-angle Glaucoma: A Meta-analysis. J Curr Glaucoma Pract 2018;12:67–84. DOI: 10.5005/jp-journals-10008-1248.
  38. Samuelson TW, Katz LJ, et al. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011;118:459–467. DOI: 10.1016/j.ophtha.2010.07.007.
  39. Landers J, Martin K, et al. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology 2011;119: 694–702. DOI: 10.1016/j.ophtha.2011.09.043.
  40. Yalvac IS, Nurozler A, et al. The results of trabeculectomy with and without Mitomycin C in young patients. Ophthalmologica 1998;212:399–403. DOI: 10.1159/000027375.
  41. Montolío Marzo S, Lanzagorta Aresti A, et al. Malignant glaucoma after XEN45 implant. Arch Soc Esp Oftalmol 2019;94:134–137. DOI: 10.1016/j.oftal.2018.10.023.
  42. Heidinger A, Schwab C, et al. A retrospective study of 199 xen45 stent implantations from 2014 to 2016. J Glaucoma 2019;28:75–79. DOI: 10.1097/IJG.0000000000001122.
  43. Grover DS, Flynn WJ, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol 2017;183:25–36. DOI: 10.1016/j.ajo.2017.07.023.
  44. Tham YC, Li X, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology 2014;121:2081–2090. DOI: 10.1016/j.ophtha.2014.05.013.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.